Literature DB >> 6170079

The pharmacology of the fluoropyrimidines.

C E Myers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6170079

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  34 in total

1.  Concentration and time dependence of the toxicity of fluorinated pyrimidines to HT 29 colorectal carcinoma cells.

Authors:  K H Link; K R Aigner; K Peschau; M Warthona; K Schwemmle; P V Danenberg
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

2.  Biochemical mechanisms for the scheduled synergism of (alpha S, 5S)-2 amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid and 5-fluorouracil in P388 leukemia.

Authors:  B Ardalan; B Chandrasekaran; H J Hrishikeshavan
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

3.  Comparison of 5-fluorouracil anabolite levels after intravenous bolus and continuous infusion.

Authors:  T A Stein; B Bailey; G P Burns
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 4.  5-Fluorouracil radiation sensitization--a brief review.

Authors:  J E Byfield
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

5.  Use of E. coli Purine Nucleoside Phosphorylase in the Treatment of Solid Tumors.

Authors:  William B Parker; Eric J Sorscher
Journal:  Curr Pharm Des       Date:  2017-11-08       Impact factor: 3.116

6.  Biochemical modulation of 5-fluorouracil with or without leucovorin by a low dose of brequinar in MGH-U1 cells.

Authors:  T L Chen; C Erlichman
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  Nonlinear pharmacokinetics for the elimination of 5-fluorouracil after intravenous administration in cancer patients.

Authors:  B J McDermott; H W van den Berg; R F Murphy
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

8.  Concurrent allopurinol and 5-fluorouracil: 5-fluoro-2'-deoxyuridylate formation and thymidylate synthase inhibition in rat colon carcinoma and in regenerating rat liver.

Authors:  M Berne; B Gustavsson; O Almersjö; C P Spears; J Waldenström
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

9.  Sequence-dependent cytotoxic effects of the combination of a new nitrosourea, fotemustine, with 5-fluorouracil plus folinic acid.

Authors:  J L Fischel; P Formento; M Berlion; J Berille; J Gioanni; J P Bizzari; G Milano
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 10.  Levamisole/fluorouracil. A review of their pharmacology and adjuvant therapeutic use in colorectal cancer.

Authors:  P Chrisp; D McTavish
Journal:  Drugs Aging       Date:  1991 Jul-Aug       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.